The Miami Herald >  Business >  Press Releases >  Biotechnology

Sign up to get the Business newsletter.

Please confirm email address:

Regular Aerobic Exercise Improves Vascular Reactivity for Patients at Risk of Developing Diabetes

Pre-diabetic patients who engage in regular aerobic exercise improve their vascular reactivity to nearly normal levels, even if no weight loss is achieved, according to research presented today at the American Association of Clinical Endocrinologists (AACE) 21st Annual Meeting & Clinical Congress in Philadelphia. Pre-diabetes is a condition that affects nearly one in every four Americans.

  • Exciting News from BIONOVA Skincare!

    /PRNewswire/ -- El Museo del Barrio's 19th Spring Gala at Cipriani held on May 17th gathered many celebrities including actress Julianna Margulies, fashion designer Carolina Herrera, bestowing Yaz Hernandez, Ruben and Isabel Toledo. The highlight of the event was honoring Narciso Rodriguez, an American fashion designer. The glamorous fundraising evening benefiting New York's leading Latino cultural institution was chaired by Nina Garcia, Alex Gonzalez and Sarah G. Wolfe.

  • Energy 1 Corporation Enters Distribution Agreement with TransBioTec

    Expanded Product & Service Options for Customers

  • The Virtual Examination Room – How Technology Allows Endocrinologists to Battle High Rate of Diabetes in Rural Areas

    Today a study was presented at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress which highlighted the benefits of using Telemedicine in the examination and treatment of patients located in remote, especially rural, areas. The prevalence of diabetes and other endocrine diseases such as obesity, thyroid disease and osteoporosis continues to rise nationally. Diabetes is particularly concerning in rural populations of the USA where its likelihood is approximately 17% higher than in urban centers. Compounding this disparity is the lack of medical specialists, especially endocrinologists, in rural areas.

  • As Medical Tattoos Gain Popularity, Guidelines Should Establish Standards and Consistency

    Medical tattoos, a permanent bodily mark used to indicate the illnesses or allergies an individual has, are gaining momentum and popularity. However, a review of medical literature indicates a lack of established guidelines in the medical community on how medical tattoos should be administered and effectively used, according to an expert today at the American Association of Clinical Endocrinologists (AACE) 21st Annual Meeting & Clinical Congress in Philadelphia.

  • Bayer HealthCare to Exhibit Innovative Device Technologies at 2012 SNM Annual Meeting

    Showcased advancements include:, - Enhancements to the MEDRAD Intego™ PET Infusion System, - Platforms for controlled administration of molecular agents for SPECT and small animal imaging procedures,

  • Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting

    /PRNewswire/ -- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced today that the Company presented two posters at the Society for Research on Biological Rhythms (SRBR) annual meeting in Destin, Florida.

  • GeneLink Reports First Quarter 2012 Financial Results

    /PRNewswire/ -- GeneLink, Inc. (OTCBB: GNLK.OB, "the Company," or "GeneLink"), a leading consumer genomics biotech company, reports financial results for the three months ended March 31, 2012.

  • IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research

    /PRNewswire/ --  IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC.PK)  announced today that it has entered a sponsored research agreement with the Institute for Cell Engineering and Regenerative Medicine (ICERM)  at the University of Florida.  A portion of the collaborative work will be to explore the physiological characteristics of the adult autologous vascular cells that are also referred to as stromal vascular fraction cells which form the basis of the IntelliCell product.  The company also intends to explore combination therapies with patent pending bio-engineered products under development.  The Company believes that the IntelliCell product is an efficient cellular delivery platform for a variety of therapeutic applications and will look to partner with technology developers.

  • Apex BioStrategists Advises On Flow Cytometry Sale To Coulter

    /PRNewswire-iReach/ -- APEX BIOSTRATEGISTS, A FULL SERVICE ADVISORY FIRM, LED THE TEAM ADVISING THE SELLERS IN THE RECENT ASSET SALE BY NPE SYSTEMS, INC. AND BLUE OCEAN BIOMEDICAL, LLC, BOTH OF PEMBROKE PINES, FLORIDA, TO BECKMAN COULTER. NPE AND BLUE OCEAN WERE TECHNOLOGY LEADERS IN THE FIELD OF FLOW CYTOMETRY WHICH PROVIDES DIAGNOSTIC BLOOD AND TISSUE TESTING FOR PATIENT MONITORING AND FOR DRUG RESEARCH. BECKMAN COULTER IS A MARKET LEADER IN THE SALE OF FLOW CYTOMETRY SYSTEMS TO HOSPITALS AND TESTING LABS THROUGHOUT THE WORLD.

  • Urologists Outraged over Government Panel's Recommendation to Stop Life-Saving Prostate Cancer Testing

    /PRNewswire/ -- The Large Urology Group Practice Association (LUGPA), representing more than 1,800 urologists, today discredited recommendations by the U.S. Preventive Services Task Force (USPSTF) to stop prostate cancer testing.

  • IVAX Diagnostics, Inc. Reports First Quarter 2012 Financial Results

    In first quarter, continues to cut operating loss to almost break-even and increase revenue and gross profit for second consecutive quarter

  • Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients

    /PRNewswire/ -- Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center of Dallas, TX are proud to announce the establishment of the SRT University™ Comprehensive Education Series for practitioners, healthcare professionals, and patients. SRT University™ will offer multi-tiered education and training curriculums for the provider and patient populations.  The objectives are to increase the awareness and proficiency in utilizing superficial radiotherapy and its many benefits to treat non-melanoma skin cancers.

  • Biovest Announces BiovaxID® ASCO Abstract Available On-line; NCI to Present Cancer Vaccine Data from Mantle Cell Lymphoma Study

    Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced that an abstract reporting new data from the BiovaxID® Phase II mantle cell lymphoma clinical trial conducted by the U.S. National Cancer Institute (NCI) is now available on-line with the significance of these results to be presented by the NCI at the 2012 American Society of Clinical Oncology Annual Meeting (ASCO 2012).

  • PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo

    /PRNewswire/ -- Amy Langan, Vice President of Marketing and Business Development, announced that PharMEDium will highlight its enhanced labeling for sterile intravenous compounded ICU Services at the National Teaching Institute (NTI) and Critical Care Exposition, May 19-24, 2012 in Orlando, Florida.

  • The UM Miller School of Medicine Wins Prestigious Designation as Center for AIDS Research

    The National Institutes of Health has recognized the University of Miami Miller School of Medicine as Florida’s first and only Center for AIDS Research (CFAR), a prestigious designation awarded to only about 20 of the nation’s most prolific and promising AIDS research institutions.

  • CytoDyn Announces Plans to Move Forward with Next Stage of Research of CytoFeline™

    CytoDyn Inc. (the "Company")(OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency virus and other antibody applications, announced today that the Company completed production of a sufficient amount of CytoFeline™, a monoclonal antibody developed by the Company for the treatment of Feline Immunodeficiency Virus ("FIV"), to allow the Company, through its wholly owned subsidiary, CytoDyn Veterinary Medicine LLC ("CVM"), to move forward with the next stage of the antibody's development. When purification of the antibody is completed, CVM will conduct in vivo efficacy tests in cats to determine the practicality of anti-LFA1 antibodies to lower viral loads in FIV-infected cats.

  • Clinical Data Published for a Phase I AADC-deficiency Trial Using a Gene Therapy Manufactured by Florida Biologix

    Florida Biologix®, a full-service biopharmaceutical development and contract manufacturing organization, provided cGMP manufacturing services to National Taiwan University Hospital under a contract signed in March 2008. Florida Biologix produced, purified, and tested a clinical batch of their novel gene therapy for a Phase I clinical trial of a rare genetic disease – AADC deficiency. The trial was led by Dr. Paul Wuh-Liang Hwu. Results of the clinical trial were published in the May 16th issue of Science Translational Medicine.

  • Biovest Retains Ferghana Partners to Evaluate Strategic Transactions

    Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI), today announced that Biovest has retained Ferghana Partners as the Company’s strategic transaction advisor to evaluate/implement creative financings and partnering opportunities on a regional or global basis for BiovaxID®, its late-stage personalized cancer vaccine for the treatment of non-Hodgkin’s lymphoma.

  • RBCC, Amarantus Move Forward with Joint Venture Discussions

    Rainbow Biosciences, the biotechnology subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that the company is currently discussing a potential joint venture with emerging biotech innovator Amarantus BioSciences (OTCBB: AMBS).

Web Search powered byYAHOO!SEARCH
Search: Horoscopes | Comics & Games | Data Sleuth

  • Most Popular

  • VIDEO


» More video

  • Marketplace

Quick Job Search


Careerbuilder.com

Miami Top Jobs